Flexible and rapid method for detecting and isolating human malignant cells
- Summary
- Malignant cancer cell detection is a key factor in effective cancer diagnosis and research. However, current methods for malignancy identification are generally expensive and time-consuming, thereby creating an unmet need for a rapid and relatively inexpensive method for detecting human malignant cells in vivo, as well as in vitro. This technology provides a method for detecting the presence of human malignant cells in a sample of tumor cells. In addition, the technology also provides a method for obtaining an enriched population of live human malignant cells. As such, the technology provides a diagnostic for both detecting and isolating malignant cancer cells in tumors in vivo and in vitro.
- Technology Benefits
- Allows flexible application for a variety of malignancies. Inexpensive.Adaptable to complement a wide range of available cell detection and isolation methods.Allows rapid diagnostic and sample enrichment response.Patent information:Patent Issued (US 7,232,891)Tech Ventures Reference: IR 379
- Technology Application
- Determining the malignancy of human tumors. Detecting malignant cells in human tumors in diagnostic assays, both in vivo and in vitro.Isolating malignant cells from a cell population for research use or for therapeutic applications.
- Detailed Technology Description
- None
- *Abstract
-
None
- *Inquiry
- Cynthia LangColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 379
- *Principal Investigator
-
- *Publications
- Krichevsky A, Campbell-Acevedo EA, Tong JY, Acevedo HF. "Immunological detection of membrane-associated human luteinizing hormone correlates with gene expression in cultured human cancer and fetal cells" Endocrinology. 1995 Mar;136(3):10349.
- *Web Links
- USPTO_1: US 6,403,326USPTO_2: US 7,232,891
- Country/Region
- USA
For more information, please click Here
